Negócios · 12/12/20001 min de leitura
Agency Information Collection Activities; Announcement of OMB Approval; Current Good Manufacturing Practices and Related Regulations for Blood and Blood Components
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Current Good Manufacturing Practices and Related Regulations for Blood and Blood Components" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.